Zoë Gabriel
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Diabetes Treatment and Management, Long-Term Effects of COVID-19, Atomic and Subatomic Physics Research
Most-Cited Works
- Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial(2022)
- → Longitudinal Lung Function Assessment of Patients Hospitalized With COVID-19 Using 1H and 129Xe Lung MRI(2023)28 cited
- → The use of echocardiography in the management of shock in critical care: a prospective, multi-centre, observational study(2024)14 cited
- → Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial(2021)7 cited
- → Cost-Effectiveness of Dapagliflozin Compared To Dpp-4 Inhibitors as Triple Therapy In Combination With Metformin and A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective(2014)2 cited
- → Program: 55th Annual Scientific Meeting The Gerontological Society of America November 22-26, 2002 Boston Marriott and Westin Copley Place Boston, MA(2002)1 cited
- → Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors as Monotherapy in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective(2014)1 cited
- Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised multicentre open adaptive multi-arm multi-stage trial(2021)
- → Multinuclear lung MRI assessment of COVID-19 patients at 6 and 12 weeks after hospital admission(2023)
- Statin Prescribing Following an Acute Coronary Syndrome: Are the NICE Guidelines Being Followed?(2011)